Literature DB >> 21558390

Systemic DNA damage related to cancer.

Olga A Martin1, Christophe E Redon, Asako J Nakamura, Jennifer S Dickey, Alexandros G Georgakilas, William M Bonner.   

Abstract

The importance of bystander effects is becoming more appreciated, as studies show they may affect the course of cancer and other chronic diseases. The term "bystander effects" refers to changes in naïve cells sharing the same milieu with cells that have been damaged. Bystander cells may be in contact with, or distant from, damaged cells. In addition, it has been shown in culture that not only physically damaged cells, but also cells that have become abnormal (i.e., cancerous or senescent) may induce bystander effects. Recently, we have shown a similar effect in animals. Mice harboring subcutaneous tumors exhibited elevated levels of DNA damage in distant organs. In contrast to cell culture, immune cells seemed to be involved in tumor-induced bystander effects in animals because CCL2-null tumor-bearing mice did not exhibit increased distant DNA damage. Here, we discuss some of the implications of these observations. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558390      PMCID: PMC3096754          DOI: 10.1158/0008-5472.CAN-10-4579

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Induction of sister chromatid exchanges by extremely low doses of alpha-particles.

Authors:  H Nagasawa; J B Little
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

Review 2.  Radiation-induced transgenerational instability.

Authors:  Yuri E Dubrova
Journal:  Oncogene       Date:  2003-10-13       Impact factor: 9.867

3.  Whole body irradiation; radiobiology or medicine?

Authors:  R H MOLE
Journal:  Br J Radiol       Date:  1953-05       Impact factor: 3.039

4.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

5.  Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

Authors:  Zvi G Fridlender; Veena Kapoor; George Buchlis; Guanjun Cheng; Jing Sun; Liang-Chuan S Wang; Sunil Singhal; Linda A Snyder; Steven M Albelda
Journal:  Am J Respir Cell Mol Biol       Date:  2010-04-15       Impact factor: 6.914

6.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.

Authors:  A Krtolica; S Parrinello; S Lockett; P Y Desprez; J Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 7.  The controversial abscopal effect.

Authors:  Joseph M Kaminski; Eric Shinohara; James Bradley Summers; Kenneth J Niermann; Allan Morimoto; Jeffrey Brousal
Journal:  Cancer Treat Rev       Date:  2005-05       Impact factor: 12.111

8.  Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.

Authors:  Mieke Gouwy; Sofie Struyf; Julie Catusse; Paul Proost; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2004-04-09       Impact factor: 4.962

Review 9.  CCL2 (monocyte chemoattractant protein-1) and cancer.

Authors:  Ilaria Conti; Barrett J Rollins
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

Review 10.  Targeting monocyte chemoattractant protein-1 signalling in disease.

Authors:  Janet Dawson; Wolfgang Miltz; Anis K Mir; Christoph Wiessner
Journal:  Expert Opin Ther Targets       Date:  2003-02       Impact factor: 6.902

View more
  15 in total

1.  Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol.

Authors:  Alexandros G Georgakilas; Christophe E Redon; Nicholas F Ferguson; Thomas B Kryston; Palak Parekh; Jennifer S Dickey; Asako J Nakamura; James B Mitchell; William M Bonner; Olga A Martin
Journal:  Cancer Lett       Date:  2014-07-25       Impact factor: 8.679

2.  Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.

Authors:  Alena Moudra; Sona Hubackova; Veronika Machalova; Marketa Vancurova; Jiri Bartek; Milan Reinis; Zdenek Hodny; Anna Jonasova
Journal:  Oncoimmunology       Date:  2016-05-13       Impact factor: 8.110

Review 3.  Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury.

Authors:  Edouard I Azzam; Jean-Paul Jay-Gerin; Debkumar Pain
Journal:  Cancer Lett       Date:  2011-12-17       Impact factor: 8.679

4.  Detection of clustered DNA lesions: Biological and clinical applications.

Authors:  Alexandros Georgakilas
Journal:  World J Biol Chem       Date:  2011-07-26

Review 5.  Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects.

Authors:  Carl N Sprung; Alesia Ivashkevich; Helen B Forrester; Christophe E Redon; Alexandros Georgakilas; Olga A Martin
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

6.  γ-H2AX as a marker for dose deposition in the brain of wistar rats after synchrotron microbeam radiation.

Authors:  Cristian Fernandez-Palomo; Carmel Mothersill; Elke Bräuer-Krisch; Jean Laissue; Colin Seymour; Elisabeth Schültke
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

7.  Microvesicles Contribute to the Bystander Effect of DNA Damage.

Authors:  Xiaozeng Lin; Fengxiang Wei; Pierre Major; Khalid Al-Nedawi; Hassan A Al Saleh; Damu Tang
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

8.  Non-targeted effects of photon and particle irradiation and the interaction with the immune system.

Authors:  Thomas E Schmid; Gabriele Multhoff
Journal:  Front Oncol       Date:  2012-07-24       Impact factor: 6.244

9.  Transmembrane voltage potential of somatic cells controls oncogene-mediated tumorigenesis at long-range.

Authors:  Brook T Chernet; Michael Levin
Journal:  Oncotarget       Date:  2014-05-30

10.  Radioprotection of targeted and bystander cells by methylproamine.

Authors:  Susanne Burdak-Rothkamm; Andrea Smith; Pavel Lobachevsky; Roger Martin; Kevin M Prise
Journal:  Strahlenther Onkol       Date:  2014-09-23       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.